0001854270 2026-07-21 2026-07-21 0001854270 1 2026-07-21 2026-07-21 iso4217:USD pure Senti Biosciences Holdings, Inc. false 60000000 0.0001381 8286 60000000 8286 0 0 8286 <table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%; margin-left: auto; margin-right: auto;"> <tr style="height: 0px; font-size: 0px;"><td style="width: 1%;"> </td><td style="width: 99%;"> </td></tr><tr style="vertical-align: top;"> <td style="padding: 0px 0pt; font-size: 10pt; vertical-align: top;"> <div style="margin-bottom: 4pt;"> (1) </div> </td> <td style="padding: 0px 5.4pt 0px 5px; text-align: left; font-size: 10pt;"> <div style="margin-bottom: 4pt;"> Capitalized terms used below but not defined herein shall have the meanings assigned to such terms in the Agreement and Plan of Merger, dated as of July 14, 2026 (the “Merger Agreement”), by and among Senti Biosciences Holdings, Inc. (the “Company”), Senti Holdings, Inc., Senti Biosciences, Inc., Celadon Partners SPV 35 Limited and Senti Merger Sub, Inc.<br/><br/><span style="letter-spacing: normal; text-align: start; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">In accordance with Rule 0-11 under the Securities Exchange Act of 1934, the filing fee has been calculated on the basis of the maximum aggregate consideration payable pursuant to the Merger Agreement, which is $60,000,000.00, representing the aggregate cap on all Milestone Payment Amounts. The filing fee equals $8,286, calculated at a rate of $138.10 per $1,000,000 of transaction value. </span><br/> </div> </td> </tr> </table> SC 14A 0001854270 EX-FILING FEES N/A PREM14A